Ginsenoside Re reduces the expression of Bcl-2 and HIF-1α in tumor xenografts both in vivo and in vitro. It induces normalization of the tumor vascular system, reduces proliferation, and promotes apoptosis in B16F10 melanomas, exerting an inhibitory effect on the growth of cutaneous melanomas (99). Here, BCL2 is linked to neoplasm.